|
 |
|
|||||||
|
|||||||||
Diabetes 51:2886-2894, 2002
© 2002 by the American Diabetes Association, Inc.
AICAR Administration Causes an Apparent Enhancement of Muscle and Liver Insulin Action in Insulin-Resistant High-Fat-Fed Rats
1 Garvan Institute of Medical Research, Sydney, New South Wales, Australia
2 Boston University School of Medicine, Boston, Massachusetts
Exercise improves insulin sensitivity. As AMP-activated protein kinase (AMPK) plays an important role in muscle metabolism during exercise, we investigated the effects of the AMPK activator 5-aminoimidazole-4-carboxamide-1-ß-D-ribofuranoside (AICAR) on insulin action in insulin-resistant high-fat-fed (HF) rats. Rats received a subcutaneous injection of 250 mg/kg AICAR (HF-AIC) or saline (HF-Con). The next day, euglycemic-hyperinsulinemic clamp studies were performed. Glucose infusion rate during the clamp was enhanced (50%) in HF-AIC compared with HF-Con rats. Insulin-stimulated glucose uptake was improved in white but not in red quadriceps, whereas glycogen synthesis was improved in both red and white quadriceps of HF-AIC rats. HF-AIC rats also showed increased insulin suppressibility of hepatic glucose output (HGO). AICAR-induced responses in both liver and muscle were accompanied by reduced malonyl-CoA content. Clamp HGO correlated closely with hepatic triglyceride content (r = 0.67, P < 0.01). Thus, a single dose of AICAR leads to an apparent enhancement in whole-body, muscle, and liver insulin action in HF rats that extends beyond the expected time of AMPK activation. Whether altered tissue lipid metabolism mediates AICAR effects on insulin action remains to be determined. Follow-up studies suggest that at least some of the post-AICAR insulin-enhancing effects also occur in normal rats. Independent of this, the results suggest that pharmacological activation of AMPK may have potential in treating insulin-resistant states and type 2 diabetes.
CiteULike 
Del.icio.us 
Digg 
Reddit 
Technorati What's this?
This article has been cited by other articles:
|
|
 |
|
  M. J. Sanders, Z. S. Ali, B. D. Hegarty, R. Heath, M. A. Snowden, and D. Carling Defining the Mechanism of Activation of AMP-activated Protein Kinase by the Small Molecule A-769662, a Member of the Thienopyridone Family J. Biol. Chem., November 9, 2007; 282(45): 32539 - 32548. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. Goransson, A. McBride, S. A. Hawley, F. A. Ross, N. Shpiro, M. Foretz, B. Viollet, D. G. Hardie, and K. Sakamoto Mechanism of Action of A-769662, a Valuable Tool for Activation of AMP-activated Protein Kinase J. Biol. Chem., November 9, 2007; 282(45): 32549 - 32560. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Z. T. Bloomgarden Insulin Resistance Concepts Diabetes Care, May 1, 2007; 30(5): 1320 - 1326. [Full Text] [PDF]
|
|
|
|
 |
|
 L. Miyamoto, T. Toyoda, T. Hayashi, S. Yonemitsu, M. Nakano, S. Tanaka, K. Ebihara, H. Masuzaki, K. Hosoda, Y. Ogawa, et al. Effect of acute activation of 5'-AMP-activated protein kinase on glycogen regulation in isolated rat skeletal muscle J Appl Physiol, March 1, 2007; 102(3): 1007 - 1013. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Sebastian, L. Herrero, D. Serra, G. Asins, and F. G. Hegardt CPT I overexpression protects L6E9 muscle cells from fatty acid-induced insulin resistance Am J Physiol Endocrinol Metab, March 1, 2007; 292(3): E677 - E686. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. C. Towler and D. G. Hardie AMP-Activated Protein Kinase in Metabolic Control and Insulin Signaling Circ. Res., February 16, 2007; 100(3): 328 - 341. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J.-S. Ju, M. A. Gitcho, C. A. Casmaer, P. B. Patil, D.-G. Han, S. A. Spencer, and J. S. Fisher Potentiation of insulin-stimulated glucose transport by the AMP-activated protein kinase Am J Physiol Cell Physiol, January 1, 2007; 292(1): C564 - C572. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. B. Birk and J. F. P. Wojtaszewski Predominant {alpha}2/{beta}2/{gamma}3 AMPK activation during exercise in human skeletal muscle J. Physiol., December 15, 2006; 577(3): 1021 - 1032. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. B. Ruderman, C. Keller, A.-M. Richard, A. K. Saha, Z. Luo, X. Xiang, M. Giralt, V. B. Ritov, E. V. Menshikova, D. E. Kelley, et al. Interleukin-6 Regulation of AMP-Activated Protein Kinase: Potential Role in the Systemic Response to Exercise and Prevention of the Metabolic Syndrome Diabetes, December 1, 2006; 55(Supplement_2): S48 - S54. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Fujii, N. Jessen, and L. J. Goodyear AMP-activated protein kinase and the regulation of glucose transport Am J Physiol Endocrinol Metab, November 1, 2006; 291(5): E867 - E877. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Christopher, C. Rantzau, Z.-P. Chen, R. Snow, B. Kemp, and F. P. Alford Impact of in vivo fatty acid oxidation blockade on glucose turnover and muscle glucose metabolism during low-dose AICAR infusion Am J Physiol Endocrinol Metab, November 1, 2006; 291(5): E1131 - E1140. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Fosgerau, C. Fledelius, K. E Pedersen, J. B Kristensen, J. R Daugaard, M. A Iglesias, E. W Kraegen, and S. M Furler Oral administration of glucose promotes intracellular partitioning of fatty acid toward storage in white but not in red muscle. J. Endocrinol., September 1, 2006; 190(3): 651 - 658. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Q. F. Collins, Y. Xiong, E. G. Lupo Jr., H.-Y. Liu, and W. Cao p38 Mitogen-activated Protein Kinase Mediates Free Fatty Acid-induced Gluconeogenesis in Hepatocytes J. Biol. Chem., August 25, 2006; 281(34): 24336 - 24344. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Zang, S. Xu, K. A. Maitland-Toolan, A. Zuccollo, X. Hou, B. Jiang, M. Wierzbicki, T. J. Verbeuren, and R. A. Cohen Polyphenols Stimulate AMP-Activated Protein Kinase, Lower Lipids, and Inhibit Accelerated Atherosclerosis in Diabetic LDL Receptor-Deficient Mice. Diabetes, August 1, 2006; 55(8): 2180 - 2191. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. K. LeBrasseur, M. Kelly, T.-S. Tsao, S. R. Farmer, A. K. Saha, N. B. Ruderman, and E. Tomas Thiazolidinediones can rapidly activate AMP-activated protein kinase in mammalian tissues Am J Physiol Endocrinol Metab, July 1, 2006; 291(1): E175 - E181. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. E. Kuhl, N. B. Ruderman, N. Musi, L. J. Goodyear, M. E. Patti, S. Crunkhorn, D. Dronamraju, A. Thorell, J. Nygren, O. Ljungkvist, et al. Exercise training decreases the concentration of malonyl-CoA and increases the expression and activity of malonyl-CoA decarboxylase in human muscle Am J Physiol Endocrinol Metab, June 1, 2006; 290(6): E1296 - E1303. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Sriwijitkamol, J. L. Ivy, C. Christ-Roberts, R. A. DeFronzo, L. J. Mandarino, and N. Musi LKB1-AMPK signaling in muscle from obese insulin-resistant Zucker rats and effects of training Am J Physiol Endocrinol Metab, May 1, 2006; 290(5): E925 - E932. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. G. Hardie and K. Sakamoto AMPK: A Key Sensor of Fuel and Energy Status in Skeletal Muscle Physiology, February 1, 2006; 21(1): 48 - 60. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Blaschke, Y. Takata, E. Caglayan, R. E. Law, and W. A. Hsueh Obesity, Peroxisome Proliferator-Activated Receptor, and Atherosclerosis in Type 2 Diabetes Arterioscler. Thromb. Vasc. Biol., January 1, 2006; 26(1): 28 - 40. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. S. Fisher, J.-S. Ju, P. J. Oppelt, J. L. Smith, A. Suzuki, and H. Esumi Muscle contractions, AICAR, and insulin cause phosphorylation of an AMPK-related kinase Am J Physiol Endocrinol Metab, December 1, 2005; 289(6): E986 - E992. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. C. Camacho, D. B. Lacy, F. D. James, E. P. Donahue, and D. H. Wasserman 5-Aminoimidazole-4-carboxamide-1-{beta}-D-ribofuranoside renders glucose output by the liver of the dog insensitive to a pharmacological increment in insulin Am J Physiol Endocrinol Metab, December 1, 2005; 289(6): E1039 - E1043. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. L. Smith, P. B. Patil, and J. S. Fisher AICAR and hyperosmotic stress increase insulin-stimulated glucose transport J Appl Physiol, September 1, 2005; 99(3): 877 - 883. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Tanaka, S. Hidaka, H. Masuzaki, S. Yasue, Y. Minokoshi, K. Ebihara, H. Chusho, Y. Ogawa, T. Toyoda, K. Sato, et al. Skeletal Muscle AMP-Activated Protein Kinase Phosphorylation Parallels Metabolic Phenotype in Leptin Transgenic Mice Under Dietary Modification Diabetes, August 1, 2005; 54(8): 2365 - 2374. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. B. Taylor, W. J. Ellingson, J. D. Lamb, D. G. Chesser, and W. W. Winder Long-chain acyl-CoA esters inhibit phosphorylation of AMP-activated protein kinase at threonine-172 by LKB1/STRAD/MO25 Am J Physiol Endocrinol Metab, June 1, 2005; 288(6): E1055 - E1061. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. F. P Wojtaszewski, J. B Birk, C. Frosig, M. Holten, H. Pilegaard, and F. Dela 5'AMP activated protein kinase expression in human skeletal muscle: effects of strength training and type 2 diabetes J. Physiol., April 15, 2005; 564(2): 563 - 573. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. R. Pencek, J. Shearer, R. C. Camacho, F. D. James, D. B. Lacy, P. T. Fueger, E. P. Donahue, W. Snead, and D. H. Wasserman 5-Aminoimidazole-4-Carboxamide-1-{beta}-D-Ribofuranoside Causes Acute Hepatic Insulin Resistance In Vivo Diabetes, February 1, 2005; 54(2): 355 - 360. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. C. Camacho, R. R. Pencek, D. B. Lacy, F. D. James, E. P. Donahue, and D. H. Wasserman Portal Venous 5-Aminoimidazole-4-Carboxamide-1-{beta}-D-Ribofuranoside Infusion Overcomes Hyperinsulinemic Suppression of Endogenous Glucose Output Diabetes, February 1, 2005; 54(2): 373 - 382. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Leclerc and G. A. Rutter AMP-Activated Protein Kinase: A New Beta-Cell Glucose Sensor?: Regulation by Amino Acids and Calcium Ions Diabetes, December 1, 2004; 53(suppl_3): S67 - S74. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M.-H. Zou, S. S. Kirkpatrick, B. J. Davis, J. S. Nelson, W. G. Wiles IV, U. Schlattner, D. Neumann, M. Brownlee, M. B. Freeman, and M. H. Goldman Activation of the AMP-activated Protein Kinase by the Anti-diabetic Drug Metformin in Vivo: ROLE OF MITOCHONDRIAL REACTIVE NITROGEN SPECIES J. Biol. Chem., October 15, 2004; 279(42): 43940 - 43951. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. J. Sigal, G. P. Kenny, D. H. Wasserman, and C. Castaneda-Sceppa Physical Activity/Exercise and Type 2 Diabetes Diabetes Care, October 1, 2004; 27(10): 2518 - 2539. [Full Text] [PDF]
|
|
|
|
|
|
M. A. Iglesias, S. M. Furler, G. J. Cooney, E. W. Kraegen, and J.-M. Ye AMP-Activated Protein Kinase Activation by AICAR Increases Both Muscle Fatty Acid and Glucose Uptake in White Muscle of Insulin-Resistant Rats In Vivo Diabetes, July 1, 2004; 53(7): 1649 - 1654. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Schrauwen and M. K.C. Hesselink Oxidative Capacity, Lipotoxicity, and Mitochondrial Damage in Type 2 Diabetes Diabetes, June 1, 2004; 53(6): 1412 - 1417. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Leclerc, W. W. Woltersdorf, G. da Silva Xavier, R. L. Rowe, S. E. Cross, G. S. Korbutt, R. V. Rajotte, R. Smith, and G. A. Rutter Metformin, but not leptin, regulates AMP-activated protein kinase in pancreatic islets: impact on glucose-stimulated insulin secretion Am J Physiol Endocrinol Metab, June 1, 2004; 286(6): E1023 - E1031. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. R. Banerjee, S. M. Rangwala, J. S. Shapiro, A. S. Rich, B. Rhoades, Y. Qi, J. Wang, M. W. Rajala, A. Pocai, P. E. Scherer, et al. Regulation of Fasted Blood Glucose by Resistin Science, February 20, 2004; 303(5661): 1195 - 1198. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Hojlund, K. J. Mustard, P. Staehr, D. G. Hardie, H. Beck-Nielsen, E. A. Richter, and J. F. P. Wojtaszewski AMPK activity and isoform protein expression are similar in muscle of obese subjects with and without type 2 diabetes Am J Physiol Endocrinol Metab, February 1, 2004; 286(2): E239 - E244. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. G. Hardie Minireview: The AMP-Activated Protein Kinase Cascade: The Key Sensor of Cellular Energy Status Endocrinology, December 1, 2003; 144(12): 5179 - 5183. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. B. Ruderman, A. K. Saha, and E. W. Kraegen Minireview: Malonyl CoA, AMP-Activated Protein Kinase, and Adiposity Endocrinology, December 1, 2003; 144(12): 5166 - 5171. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. A. Morrow, F. Foufelle, J. M. C. Connell, J. R. Petrie, G. W. Gould, and I. P. Salt Direct Activation of AMP-activated Protein Kinase Stimulates Nitric-oxide Synthesis in Human Aortic Endothelial Cells J. Biol. Chem., August 22, 2003; 278(34): 31629 - 31639. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. I. Itani, A. K. Saha, T. G. Kurowski, H. R. Coffin, K. Tornheim, and N. B. Ruderman Glucose Autoregulates Its Uptake in Skeletal Muscle: Involvement of AMP-Activated Protein Kinase Diabetes, July 1, 2003; 52(7): 1635 - 1640. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. K. T. Lam, A. Carpentier, G. F. Lewis, G. van de Werve, I. G. Fantus, and A. Giacca Mechanisms of the free fatty acid-induced increase in hepatic glucose production Am J Physiol Endocrinol Metab, May 1, 2003; 284(5): E863 - E873. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Tomas, T.-S. Tsao, A. K. Saha, H. E. Murrey, C. c. Zhang, S. I. Itani, H. F. Lodish, and N. B. Ruderman Enhanced muscle fat oxidation and glucose transport by ACRP30 globular domain: Acetyl-CoA carboxylase inhibition and AMP-activated protein kinase activation PNAS, December 10, 2002; 99(25): 16309 - 16313. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Diabetes | Diabetes Care | Clinical Diabetes | Diabetes Spectrum |